Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:102-103 (10 January), doi:10.1136/bmj.328.7431.102
John Strang, director1, Rudi Fortson, barrister2
1 National Addiction Centre, King's College London, London SE5 8AF, 2 London WC1R 4HD
Correspondence to: J Strang johnstrang@iop.kcl.ac.uk
| The first 150 words of the full text of this article appear below. |
Harm reduction policies and practices (where anything goes, if it actually reduces harm) have fundamentally altered our approach to the drugs problem. Two innovations were recently considered by the Home Affairs Select Committeesupervised injecting centres and supervised injectable maintenance clinicsbut with unhelpful confusion between the two.1 They have different target populations, potential benefits, and legal obstacles.
Supervised injecting centres (also known as supervised drug consumption rooms or fixing rooms) are essentially public access facilities, perhaps the injecting drug user's equivalent of a pub or bar, where the injection of unknown drugs by unknown persons should be safer by virtue of supervision and consequent speed of response in the event of overdose.2 The target population is all injecting drug misusersregardless of whether or not they are dependent or wish to change their drug taking habits. Perhaps providing this safer haven may lead some to seek treatment. But this is not the
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses